About Us
Our Story
Versiti Clinical Trials brings the collective power of three organizations—Cenetron, Salus IRB and Versiti—to maximize potential to serve clients in the growing clinical trials world. Our spectrum of services range from logistics and testing to IRB review. We’re passionate about providing customized solutions to support our clients’ unique clinical trial needs.
- Long history of helping clinical trial partners accelerate speed-to-market
- Seamless coordination, consultative expertise and flexible offerings
- More than 30 practicing physicians and investigators on staff
- Independent, nonprofit IRB and testing services
Our Brands
Cenetron, Salus IRB and Versiti come together as Versiti Clinical Trials to provide better, more comprehensive clinical trial services and agile processes for our clinical trial partners.
Cenetron Diagnostics
As an industry-leading central laboratory service provider, Cenetron is committed to efficiency and comprehensive support for phase I-IV clinical trials. Cenetron offers a host of services, including laboratory testing, data management, fully customized collection kits, clinical supplies, biosample storage and logistics, and more.
Salus IRB
An AAHRPP-accredited IRB, Salus IRB has more than 35 years of experience in providing professional IRB services with nimble and high-touch customer service. Salus is committed to the highest standards in human research protection.
Versiti
Versiti’s expertise in blood health innovation has evolved to support a large range of clinical trial services, including medical device studies and specialized lab testing with an emphasis in hematology, transfusion, transplant testing and assay development. Versiti is a 501(c)(3) nonprofit organization.
Executive Leadership
Get to know the Versiti Clinical Trials executive leadership team and learn more about our commitment to unparalleled clinical trial services.
Locations
Versiti Clinical Trials’ Cenetron and Salus IRB are located in Austin, Texas; Versiti is located in Milwaukee, Wisconsin.